Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

7.86
Delayed Data
As of Mar 23
 +0.16 / +2.08%
Today’s Change
6.47
Today|||52-Week Range
16.30
+9.78%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close7.70
Today’s open7.80
Day’s range7.71 - 7.98
Volume545,042
Average volume (3 months)691,270
Market cap$310.3M
Dividend yield--
Data as of 03/23/2017

Growth & Valuation

Earnings growth (last year)-23.81%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.69
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc-0.19-2.20%
SVASinovac Biotech Ltd-0.03-0.52%
TTPHTetraphase Pharmaceu...+0.26+3.32%
CMRXChimerix Inc+0.27+4.34%
Data as of 03/23/2017

Financials

Last reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$4.0M
Annual profit (last year)-$73.6M
Net profit margin-1,841.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts


Search for Jobs